Top Story

Drinking coffee reduces risk for death, negative health outcomes

November 22, 2017

Consuming coffee lowered the risk for death and a broad spectrum of health outcomes, according to a report recently published in BMJ.

“It is important to systematically assess the totality of higher level evidence of the effects of coffee consumption on all health outcomes,” Robin Poole, MB, ChB, MSc, of the academic unit of primary care and population sciences, University of Southampton, United Kingdom, and colleagues wrote. “This approach can help contextualize the magnitude of the association across health outcomes and importantly assess the existing research for any harm that could be associated with increased consumption.”


Should children with type 1 diabetes and dyslipidemia be treated with lipid-lowering medications?

Endocrine Today, November 2017
PoinT Cardiovascular disease remains the leading cause of mortality in people with diabetes. This includes patients diagnosed with type 1 diabetes in childhood…
Cover Story

As obesity rate rises, ‘double diabetes’ looms large

Endocrine Today, November 2017
An October report from the CDC’s National Center for Health Statistics revealed a startling increase in the prevalence of obesity in the U.S., with rates now…
Diabetes in Real Life

Daily foot care can prevent later problems

Endocrine Today, November 2017
In this issue, Susan Weiner, MS, RDN, CDE, CDN, talks with podiatrist Mark Hinkes, DPM, about foot problems that commonly affect people with diabetes. Hinkes:

Back-to-basics approach to diabetic neuropathy can prevent, relieve painful symptoms

Endocrine Today, November 2017
Diabetic neuropathy remains one of the most common chronic complications of both type 1 and type 2 diabetes. According to the National Institute of Neurological…
More Headlines »

Ace the Case: A 39-Year-Old Man with Progressive Weight Gain

No commercial support for this activity.

This “Ace the Case” activity will use a case study to discuss obesity management in a patient with progressive weight…
More »
Meeting News

VIDEO: Novel protein plus cold exposure promising for preventing obesity

October 31, 2017
More »
Resource Centers



Back to the Future: Clinical Experience with and Access to Lipid-Lowering Agents of the Past, Present, and Future

This activity is supported by educational funding provided by Amgen and Sanofi US and Regeneron Pharmaceuticals.

With each passing year we gain new insight and understanding around the clinical utilization of lipid-lowering…
More »
Current Issues
View the Current Issue